Odonate Therapeutics, Inc.
ODTC · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $128,916,000 | $152,600 | $150,876 | $1,892,352 |
| - Cash | $39,544 | $10,722 | $68,892 | $157,265 |
| + Debt | $2,299 | $2,768 | $4,667 | $5,326 |
| Enterprise Value | $128,878,755 | $144,646 | $86,651 | $1,740,413 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$21 | -$342 | -$1,051 | -$870 |
| % Margin | – | – | – | – |
| EBITDA | $9,465 | $9,980 | -$67,264 | -$125,480 |
| % Margin | – | – | – | – |
| Net Income | $7,325 | $42,940 | -$68,315 | -$126,350 |
| % Margin | – | – | – | – |
| EPS Diluted | 6.805 | 39,311.069 | -48,889.111 | -102,517.747 |
| % Growth | -100% | 180.4% | 52.3% | – |
| Operating Cash Flow | $8,740 | $1,795 | -$75,725 | -$113,130 |
| Capital Expenditures | $0 | $0 | -$26 | -$432 |
| Free Cash Flow | $8,740 | $1,795 | -$75,751 | -$113,562 |